Safety and Efficacy Study of KP-1461 to Treat ART-Experienced HIV+ Patients

NCT00504452 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

27

Enrollment

INDUSTRY

Sponsor class

Stopped Corroboration of supporting in vitro data \- Data successfully corroborated 2009

Conditions

HIV Infections

Interventions

DRUG: KP-1461

Sponsor

Koronis Pharmaceuticals.